missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. SLAM/CD150 Antibody (SR2260), Novus Biologicals™
  7. 18643225

SLAM/CD150 Antibody (SR2260), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-22222-100ul

 View more versions of this product

Product Code. 18643225

  • £341.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

SLAM/CD150 Monoclonal antibody specifically detects SLAM/CD150 in Human samples. It is validated for Western Blot, Flow Cytometry, Immunoprecipitation
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SLAM/CD150
Monoclonal
Unconjugated
PBS, pH 7.4, 150mM NaCl, 50% glycerol.
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Western Blot, Flow Cytometry, Immunoprecipitation
SR2260
Western Blot 1:500-1:2000, Flow Cytometry 1:50, Immunoprecipitation 1:50
CD 150, CD150IPO-3, CDw150, signaling lymphocytic activation molecule, signaling lymphocytic activation molecule family member 1, SLAMCD150 antigen
A synthesized peptide derived from human SLAM/CD150 (Uniprot #: Q13291)
100 μg
Cell Cycle and Replication, Hematopoietic Stem Cell Markers, Phospho Specific, Stem Cell Markers
6504
Store at -20° C. Avoid freeze/thaw cycles.
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.